BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 9515778)

  • 1. Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock.
    Vervloet MG; Thijs LG; Hack CE
    Semin Thromb Hemost; 1998; 24(1):33-44. PubMed ID: 9515778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock.
    Mavrommatis AC; Theodoridis T; Economou M; Kotanidou A; El Ali M; Christopoulou-Kokkinou V; Zakynthinos SG
    Intensive Care Med; 2001 Dec; 27(12):1853-9. PubMed ID: 11797019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinolysis in disseminated intravascular coagulation.
    Hack CE
    Semin Thromb Hemost; 2001 Dec; 27(6):633-8. PubMed ID: 11740686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disseminated intravascular coagulation: What's new?
    Levi M
    Crit Care Clin; 2005 Jul; 21(3):449-67. PubMed ID: 15992667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis and treatment of disseminated intravascular coagulation in the septic patient.
    Levi M
    J Crit Care; 2001 Dec; 16(4):167-77. PubMed ID: 11815902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Coagulation tests in septic surgical patients].
    Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
    Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome.
    Egbring R; Seitz R; Blanke H; Leititis J; Kesper HJ; Burghard R; Fuchs G; Lerch L
    Behring Inst Mitt; 1986 Feb; (79):87-103. PubMed ID: 2424425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
    Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
    Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
    Idell S
    Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma antigen levels of thrombin-activatable fibrinolysis inhibitor did not differ in patients with or without disseminated intravascular coagulation.
    Chen CC; Lee KD; Gau JP; Yu YB; You JY; Lee SC; Hsu HC; Chau WK; Ho CH
    Ann Hematol; 2005 Oct; 84(10):675-80. PubMed ID: 16007424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation between coagulation/fibrinolysis and lactate in the course of human septic shock.
    Hartemink KJ; Hack CE; Groeneveld AB
    J Clin Pathol; 2010 Nov; 63(11):1021-6. PubMed ID: 20870661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of tumor necrosis factor in the pathogenesis of intravascular coagulopathy of sepsis: potential new therapeutic implications.
    Aderka D
    Isr J Med Sci; 1991 Jan; 27(1):52-60. PubMed ID: 1995504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients.
    Voves C; Wuillemin WA; Zeerleder S
    Blood Coagul Fibrinolysis; 2006 Sep; 17(6):445-51. PubMed ID: 16905947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activation of neutrophil elastase-mediated fibrinolysis is not sufficient to overcome the fibrinolytic shutdown of disseminated intravascular coagulation associated with systemic inflammation.
    Gando S; Hayakawa M; Sawamura A; Hoshino H; Oshiro A; Kubota N; Jesmin S
    Thromb Res; 2007; 121(1):67-73. PubMed ID: 17397908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiopathophysiology of disseminated intravascular coagulation.
    Bakhshi S; Arya LS
    J Assoc Physicians India; 2003 Aug; 51():796-800. PubMed ID: 14651143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome.
    Gando S; Kameue T; Nanzaki S; Nakanishi Y
    Thromb Haemost; 1996 Feb; 75(2):224-8. PubMed ID: 8815564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of DIC in multiple organ failure.
    Kidokoro A; Iba T; Hong J
    Int J Surg Investig; 2000; 2(1):73-80. PubMed ID: 12774341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sepsis, thrombosis and organ dysfunction.
    Semeraro N; Ammollo CT; Semeraro F; Colucci M
    Thromb Res; 2012 Mar; 129(3):290-5. PubMed ID: 22061311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinolysis and coagulation in patients with infectious disease and sepsis.
    Philippé J; Offner F; Declerck PJ; Leroux-Roels G; Vogelaers D; Baele G; Collen D
    Thromb Haemost; 1991 Mar; 65(3):291-5. PubMed ID: 1904655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.